This research report provides a comprehensive analysis of the Microneedles for Trans & Intradermal Drug Delivery market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Microneedles for Trans & Intradermal Drug Delivery market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Microneedles for Trans & Intradermal Drug Delivery, challenges faced by the industry, and potential opportunities for market players.
The global Microneedles for Trans & Intradermal Drug Delivery market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Microneedles for Trans & Intradermal Drug Delivery market presents opportunities for various stakeholders, including Drugs, Vaccines. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Microneedles for Trans & Intradermal Drug Delivery market. Additionally, the growing consumer demand present avenues for market expansion.
The global Microneedles for Trans & Intradermal Drug Delivery market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
Key Features:
The research report on the Microneedles for Trans & Intradermal Drug Delivery market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Microneedles for Trans & Intradermal Drug Delivery market.
Market Overview: The report provides a comprehensive overview of the Microneedles for Trans & Intradermal Drug Delivery market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Solid Microneedles, Hollow Microneedles), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Microneedles for Trans & Intradermal Drug Delivery market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Microneedles for Trans & Intradermal Drug Delivery market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Microneedles for Trans & Intradermal Drug Delivery market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Microneedles for Trans & Intradermal Drug Delivery market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Microneedles for Trans & Intradermal Drug Delivery market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Microneedles for Trans & Intradermal Drug Delivery market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Microneedles for Trans & Intradermal Drug Delivery, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Microneedles for Trans & Intradermal Drug Delivery market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Microneedles for Trans & Intradermal Drug Delivery market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Solid Microneedles
Hollow Microneedles
Dissolvable Microneedles
Market segment by Application
Drugs
Vaccines
Proteins
Peptides
Others
Global Microneedles for Trans & Intradermal Drug Delivery Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Becton Dickinson
Nanopass Technologies
Radius Health
Clearside Biomedical
Dr. Prausnitz Group
Zosano Pharma
Corium International
Circassia
Valeritas, Inc.
BD Medical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Microneedles for Trans & Intradermal Drug Delivery, market overview.
Chapter 2: Global Microneedles for Trans & Intradermal Drug Delivery market size in revenue and volume.
Chapter 3: Detailed analysis of Microneedles for Trans & Intradermal Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Microneedles for Trans & Intradermal Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Microneedles for Trans & Intradermal Drug Delivery capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Microneedles for Trans & Intradermal Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Microneedles for Trans & Intradermal Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Microneedles for Trans & Intradermal Drug Delivery Overall Market Size
2.1 Global Microneedles for Trans & Intradermal Drug Delivery Market Size: 2023 VS 2030
2.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Microneedles for Trans & Intradermal Drug Delivery Sales: 2019-2030
3 Company Landscape
3.1 Top Microneedles for Trans & Intradermal Drug Delivery Players in Global Market
3.2 Top Global Microneedles for Trans & Intradermal Drug Delivery Companies Ranked by Revenue
3.3 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Companies
3.4 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Companies
3.5 Global Microneedles for Trans & Intradermal Drug Delivery Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Microneedles for Trans & Intradermal Drug Delivery Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Microneedles for Trans & Intradermal Drug Delivery Product Type
3.8 Tier 1, Tier 2 and Tier 3 Microneedles for Trans & Intradermal Drug Delivery Players in Global Market
3.8.1 List of Global Tier 1 Microneedles for Trans & Intradermal Drug Delivery Companies
3.8.2 List of Global Tier 2 and Tier 3 Microneedles for Trans & Intradermal Drug Delivery Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Microneedles for Trans & Intradermal Drug Delivery Market Size Markets, 2023 & 2030
4.1.2 Solid Microneedles
4.1.3 Hollow Microneedles
4.1.4 Dissolvable Microneedles
4.2 By Type - Global Microneedles for Trans & Intradermal Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Microneedles for Trans & Intradermal Drug Delivery Revenue, 2019-2024
4.2.2 By Type - Global Microneedles for Trans & Intradermal Drug Delivery Revenue, 2025-2030
4.2.3 By Type - Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2019-2030
4.3 By Type - Global Microneedles for Trans & Intradermal Drug Delivery Sales & Forecasts
4.3.1 By Type - Global Microneedles for Trans & Intradermal Drug Delivery Sales, 2019-2024
4.3.2 By Type - Global Microneedles for Trans & Intradermal Drug Delivery Sales, 2025-2030
4.3.3 By Type - Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share, 2019-2030
4.4 By Type - Global Microneedles for Trans & Intradermal Drug Delivery Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Microneedles for Trans & Intradermal Drug Delivery Market Size, 2023 & 2030
5.1.2 Drugs
5.1.3 Vaccines
5.1.4 Proteins
5.1.5 Peptides
5.1.6 Others
5.2 By Application - Global Microneedles for Trans & Intradermal Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Microneedles for Trans & Intradermal Drug Delivery Revenue, 2019-2024
5.2.2 By Application - Global Microneedles for Trans & Intradermal Drug Delivery Revenue, 2025-2030
5.2.3 By Application - Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2019-2030
5.3 By Application - Global Microneedles for Trans & Intradermal Drug Delivery Sales & Forecasts
5.3.1 By Application - Global Microneedles for Trans & Intradermal Drug Delivery Sales, 2019-2024
5.3.2 By Application - Global Microneedles for Trans & Intradermal Drug Delivery Sales, 2025-2030
5.3.3 By Application - Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share, 2019-2030
5.4 By Application - Global Microneedles for Trans & Intradermal Drug Delivery Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Microneedles for Trans & Intradermal Drug Delivery Market Size, 2023 & 2030
6.2 By Region - Global Microneedles for Trans & Intradermal Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Microneedles for Trans & Intradermal Drug Delivery Revenue, 2019-2024
6.2.2 By Region - Global Microneedles for Trans & Intradermal Drug Delivery Revenue, 2025-2030
6.2.3 By Region - Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2019-2030
6.3 By Region - Global Microneedles for Trans & Intradermal Drug Delivery Sales & Forecasts
6.3.1 By Region - Global Microneedles for Trans & Intradermal Drug Delivery Sales, 2019-2024
6.3.2 By Region - Global Microneedles for Trans & Intradermal Drug Delivery Sales, 2025-2030
6.3.3 By Region - Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Microneedles for Trans & Intradermal Drug Delivery Revenue, 2019-2030
6.4.2 By Country - North America Microneedles for Trans & Intradermal Drug Delivery Sales, 2019-2030
6.4.3 US Microneedles for Trans & Intradermal Drug Delivery Market Size, 2019-2030
6.4.4 Canada Microneedles for Trans & Intradermal Drug Delivery Market Size, 2019-2030
6.4.5 Mexico Microneedles for Trans & Intradermal Drug Delivery Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Microneedles for Trans & Intradermal Drug Delivery Revenue, 2019-2030
6.5.2 By Country - Europe Microneedles for Trans & Intradermal Drug Delivery Sales, 2019-2030
6.5.3 Germany Microneedles for Trans & Intradermal Drug Delivery Market Size, 2019-2030
6.5.4 France Microneedles for Trans & Intradermal Drug Delivery Market Size, 2019-2030
6.5.5 U.K. Microneedles for Trans & Intradermal Drug Delivery Market Size, 2019-2030
6.5.6 Italy Microneedles for Trans & Intradermal Drug Delivery Market Size, 2019-2030
6.5.7 Russia Microneedles for Trans & Intradermal Drug Delivery Market Size, 2019-2030
6.5.8 Nordic Countries Microneedles for Trans & Intradermal Drug Delivery Market Size, 2019-2030
6.5.9 Benelux Microneedles for Trans & Intradermal Drug Delivery Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Microneedles for Trans & Intradermal Drug Delivery Revenue, 2019-2030
6.6.2 By Region - Asia Microneedles for Trans & Intradermal Drug Delivery Sales, 2019-2030
6.6.3 China Microneedles for Trans & Intradermal Drug Delivery Market Size, 2019-2030
6.6.4 Japan Microneedles for Trans & Intradermal Drug Delivery Market Size, 2019-2030
6.6.5 South Korea Microneedles for Trans & Intradermal Drug Delivery Market Size, 2019-2030
6.6.6 Southeast Asia Microneedles for Trans & Intradermal Drug Delivery Market Size, 2019-2030
6.6.7 India Microneedles for Trans & Intradermal Drug Delivery Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Microneedles for Trans & Intradermal Drug Delivery Revenue, 2019-2030
6.7.2 By Country - South America Microneedles for Trans & Intradermal Drug Delivery Sales, 2019-2030
6.7.3 Brazil Microneedles for Trans & Intradermal Drug Delivery Market Size, 2019-2030
6.7.4 Argentina Microneedles for Trans & Intradermal Drug Delivery Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales, 2019-2030
6.8.3 Turkey Microneedles for Trans & Intradermal Drug Delivery Market Size, 2019-2030
6.8.4 Israel Microneedles for Trans & Intradermal Drug Delivery Market Size, 2019-2030
6.8.5 Saudi Arabia Microneedles for Trans & Intradermal Drug Delivery Market Size, 2019-2030
6.8.6 UAE Microneedles for Trans & Intradermal Drug Delivery Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Becton Dickinson
7.1.1 Becton Dickinson Company Summary
7.1.2 Becton Dickinson Business Overview
7.1.3 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.1.4 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2019-2024)
7.1.5 Becton Dickinson Key News & Latest Developments
7.2 Nanopass Technologies
7.2.1 Nanopass Technologies Company Summary
7.2.2 Nanopass Technologies Business Overview
7.2.3 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.2.4 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2019-2024)
7.2.5 Nanopass Technologies Key News & Latest Developments
7.3 Radius Health
7.3.1 Radius Health Company Summary
7.3.2 Radius Health Business Overview
7.3.3 Radius Health Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.3.4 Radius Health Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2019-2024)
7.3.5 Radius Health Key News & Latest Developments
7.4 Clearside Biomedical
7.4.1 Clearside Biomedical Company Summary
7.4.2 Clearside Biomedical Business Overview
7.4.3 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.4.4 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2019-2024)
7.4.5 Clearside Biomedical Key News & Latest Developments
7.5 Dr. Prausnitz Group
7.5.1 Dr. Prausnitz Group Company Summary
7.5.2 Dr. Prausnitz Group Business Overview
7.5.3 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.5.4 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2019-2024)
7.5.5 Dr. Prausnitz Group Key News & Latest Developments
7.6 Zosano Pharma
7.6.1 Zosano Pharma Company Summary
7.6.2 Zosano Pharma Business Overview
7.6.3 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.6.4 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2019-2024)
7.6.5 Zosano Pharma Key News & Latest Developments
7.7 Corium International
7.7.1 Corium International Company Summary
7.7.2 Corium International Business Overview
7.7.3 Corium International Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.7.4 Corium International Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2019-2024)
7.7.5 Corium International Key News & Latest Developments
7.8 Circassia
7.8.1 Circassia Company Summary
7.8.2 Circassia Business Overview
7.8.3 Circassia Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.8.4 Circassia Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2019-2024)
7.8.5 Circassia Key News & Latest Developments
7.9 Valeritas, Inc.
7.9.1 Valeritas, Inc. Company Summary
7.9.2 Valeritas, Inc. Business Overview
7.9.3 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.9.4 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2019-2024)
7.9.5 Valeritas, Inc. Key News & Latest Developments
7.10 BD Medical
7.10.1 BD Medical Company Summary
7.10.2 BD Medical Business Overview
7.10.3 BD Medical Microneedles for Trans & Intradermal Drug Delivery Major Product Offerings
7.10.4 BD Medical Microneedles for Trans & Intradermal Drug Delivery Sales and Revenue in Global (2019-2024)
7.10.5 BD Medical Key News & Latest Developments
8 Global Microneedles for Trans & Intradermal Drug Delivery Production Capacity, Analysis
8.1 Global Microneedles for Trans & Intradermal Drug Delivery Production Capacity, 2019-2030
8.2 Microneedles for Trans & Intradermal Drug Delivery Production Capacity of Key Manufacturers in Global Market
8.3 Global Microneedles for Trans & Intradermal Drug Delivery Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Microneedles for Trans & Intradermal Drug Delivery Supply Chain Analysis
10.1 Microneedles for Trans & Intradermal Drug Delivery Industry Value Chain
10.2 Microneedles for Trans & Intradermal Drug Delivery Upstream Market
10.3 Microneedles for Trans & Intradermal Drug Delivery Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Microneedles for Trans & Intradermal Drug Delivery Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Microneedles for Trans & Intradermal Drug Delivery in Global Market
Table 2. Top Microneedles for Trans & Intradermal Drug Delivery Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Share by Companies, 2019-2024
Table 5. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Companies, (K Units), 2019-2024
Table 6. Global Microneedles for Trans & Intradermal Drug Delivery Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Microneedles for Trans & Intradermal Drug Delivery Price (2019-2024) & (USD/Unit)
Table 8. Global Manufacturers Microneedles for Trans & Intradermal Drug Delivery Product Type
Table 9. List of Global Tier 1 Microneedles for Trans & Intradermal Drug Delivery Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Microneedles for Trans & Intradermal Drug Delivery Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Microneedles for Trans & Intradermal Drug Delivery Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Microneedles for Trans & Intradermal Drug Delivery Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), 2019-2024
Table 15. By Type - Global Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), 2025-2030
Table 16. By Application ? Global Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Microneedles for Trans & Intradermal Drug Delivery Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Microneedles for Trans & Intradermal Drug Delivery Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), 2019-2024
Table 20. By Application - Global Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), 2025-2030
Table 21. By Region ? Global Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Microneedles for Trans & Intradermal Drug Delivery Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Microneedles for Trans & Intradermal Drug Delivery Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), 2019-2024
Table 25. By Region - Global Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), 2025-2030
Table 26. By Country - North America Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Microneedles for Trans & Intradermal Drug Delivery Sales, (K Units), 2019-2024
Table 29. By Country - North America Microneedles for Trans & Intradermal Drug Delivery Sales, (K Units), 2025-2030
Table 30. By Country - Europe Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Microneedles for Trans & Intradermal Drug Delivery Sales, (K Units), 2019-2024
Table 33. By Country - Europe Microneedles for Trans & Intradermal Drug Delivery Sales, (K Units), 2025-2030
Table 34. By Region - Asia Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Microneedles for Trans & Intradermal Drug Delivery Sales, (K Units), 2019-2024
Table 37. By Region - Asia Microneedles for Trans & Intradermal Drug Delivery Sales, (K Units), 2025-2030
Table 38. By Country - South America Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Microneedles for Trans & Intradermal Drug Delivery Sales, (K Units), 2019-2024
Table 41. By Country - South America Microneedles for Trans & Intradermal Drug Delivery Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales, (K Units), 2025-2030
Table 46. Becton Dickinson Company Summary
Table 47. Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 48. Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 49. Becton Dickinson Key News & Latest Developments
Table 50. Nanopass Technologies Company Summary
Table 51. Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 52. Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 53. Nanopass Technologies Key News & Latest Developments
Table 54. Radius Health Company Summary
Table 55. Radius Health Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 56. Radius Health Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 57. Radius Health Key News & Latest Developments
Table 58. Clearside Biomedical Company Summary
Table 59. Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 60. Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 61. Clearside Biomedical Key News & Latest Developments
Table 62. Dr. Prausnitz Group Company Summary
Table 63. Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 64. Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 65. Dr. Prausnitz Group Key News & Latest Developments
Table 66. Zosano Pharma Company Summary
Table 67. Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 68. Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 69. Zosano Pharma Key News & Latest Developments
Table 70. Corium International Company Summary
Table 71. Corium International Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 72. Corium International Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 73. Corium International Key News & Latest Developments
Table 74. Circassia Company Summary
Table 75. Circassia Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 76. Circassia Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 77. Circassia Key News & Latest Developments
Table 78. Valeritas, Inc. Company Summary
Table 79. Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 80. Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 81. Valeritas, Inc. Key News & Latest Developments
Table 82. BD Medical Company Summary
Table 83. BD Medical Microneedles for Trans & Intradermal Drug Delivery Product Offerings
Table 84. BD Medical Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 85. BD Medical Key News & Latest Developments
Table 86. Microneedles for Trans & Intradermal Drug Delivery Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 87. Global Microneedles for Trans & Intradermal Drug Delivery Capacity Market Share of Key Manufacturers, 2022-2024
Table 88. Global Microneedles for Trans & Intradermal Drug Delivery Production by Region, 2019-2024 (K Units)
Table 89. Global Microneedles for Trans & Intradermal Drug Delivery Production by Region, 2025-2030 (K Units)
Table 90. Microneedles for Trans & Intradermal Drug Delivery Market Opportunities & Trends in Global Market
Table 91. Microneedles for Trans & Intradermal Drug Delivery Market Drivers in Global Market
Table 92. Microneedles for Trans & Intradermal Drug Delivery Market Restraints in Global Market
Table 93. Microneedles for Trans & Intradermal Drug Delivery Raw Materials
Table 94. Microneedles for Trans & Intradermal Drug Delivery Raw Materials Suppliers in Global Market
Table 95. Typical Microneedles for Trans & Intradermal Drug Delivery Downstream
Table 96. Microneedles for Trans & Intradermal Drug Delivery Downstream Clients in Global Market
Table 97. Microneedles for Trans & Intradermal Drug Delivery Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Microneedles for Trans & Intradermal Drug Delivery Segment by Type in 2023
Figure 2. Microneedles for Trans & Intradermal Drug Delivery Segment by Application in 2023
Figure 3. Global Microneedles for Trans & Intradermal Drug Delivery Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Microneedles for Trans & Intradermal Drug Delivery Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Microneedles for Trans & Intradermal Drug Delivery Revenue, 2019-2030 (US$, Mn)
Figure 7. Microneedles for Trans & Intradermal Drug Delivery Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Microneedles for Trans & Intradermal Drug Delivery Revenue in 2023
Figure 9. By Type - Global Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2019-2030
Figure 11. By Type - Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share, 2019-2030
Figure 12. By Type - Global Microneedles for Trans & Intradermal Drug Delivery Price (USD/Unit), 2019-2030
Figure 13. By Application - Global Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2019-2030
Figure 15. By Application - Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share, 2019-2030
Figure 16. By Application - Global Microneedles for Trans & Intradermal Drug Delivery Price (USD/Unit), 2019-2030
Figure 17. By Region - Global Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2019-2030
Figure 20. By Region - Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share, 2019-2030
Figure 21. By Country - North America Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2019-2030
Figure 22. By Country - North America Microneedles for Trans & Intradermal Drug Delivery Sales Market Share, 2019-2030
Figure 23. US Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Microneedles for Trans & Intradermal Drug Delivery Sales Market Share, 2019-2030
Figure 28. Germany Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 29. France Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Microneedles for Trans & Intradermal Drug Delivery Sales Market Share, 2019-2030
Figure 37. China Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 41. India Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2019-2030
Figure 43. By Country - South America Microneedles for Trans & Intradermal Drug Delivery Sales Market Share, 2019-2030
Figure 44. Brazil Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales Market Share, 2019-2030
Figure 48. Turkey Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$, Mn), 2019-2030
Figure 52. Global Microneedles for Trans & Intradermal Drug Delivery Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Microneedles for Trans & Intradermal Drug Delivery by Region, 2023 VS 2030
Figure 54. Microneedles for Trans & Intradermal Drug Delivery Industry Value Chain
Figure 55. Marketing Channels
